Literature DB >> 2356805

Cognitive impairment and mortality: a study of possible confounders.

I Y Liu1, A Z LaCroix, L R White, S J Kittner, P A Wolf.   

Abstract

Baseline neuropsychological function was assessed in 2,123 Framingham Heart Study participants and was related to mortality over an 8- to 10-year follow-up period. During that time, 573 persons died. Using Cox proportional hazards models, the authors showed poor cognitive function to be consistently associated with an increased risk of death. This association persisted after adjustment for the confounding effects of age, education, and illness. Subjects scoring below the 26th percentile of performance were at increased risk of mortality compared with high scorers (the relative risk was 1.3 for the 11th percentile-25th percentile and 1.7 for the 1st percentile-10th percentile).

Entities:  

Mesh:

Year:  1990        PMID: 2356805     DOI: 10.1093/oxfordjournals.aje.a115625

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  23 in total

1.  Does cognition predict mortality in midlife? Results from the Whitehall II cohort study.

Authors:  Séverine Sabia; Alice Guéguen; Michael G Marmot; Martin J Shipley; Joël Ankri; Archana Singh-Manoux
Journal:  Neurobiol Aging       Date:  2008-06-09       Impact factor: 4.673

2.  Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors.

Authors:  Z Guo; M Viitanen; B Winblad
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

3.  The prevalence of cognitive impairment among African-American patients with congestive heart failure.

Authors:  Abimbola Akomolafe; Alexander Quarshie; Patricia Jackson; Jerome Thomas; Orlando Deffer; Adefisayo Oduwole; Anekwe Onwuanyi; Rigobert Lapu-Bula; Gregory Strayhorn; Elizabeth Ofili; Robert Mayberry
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

4.  Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults.

Authors:  M E Salive; S Satterfield; A M Ostfeld; R B Wallace; R J Havlik
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

5.  Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.

Authors:  V P Prasher; S G Sajith; P Mehta; W B Zigman; N Schupf
Journal:  Int J Geriatr Psychiatry       Date:  2010-02       Impact factor: 3.485

6.  Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Takashi Umeda; Ayako Kaneda; Yasushi Sato; Ippei Takahashi; Masashi Matsuzaka; Kazuma Danjo; Shigeyuki Nakaji; Sunao Kaneko
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

7.  Cognitive impairment and mortality in older community residents.

Authors:  H R Kelman; C Thomas; G J Kennedy; J Cheng
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

8.  Cognitive impairment and mortality in a cohort of elderly people.

Authors:  C R Gale; C N Martyn; C Cooper
Journal:  BMJ       Date:  1996-03-09

9.  Cognitive decline and mortality in a community-based cohort: the Monongahela Valley Independent Elders Survey.

Authors:  Laurie L Lavery; Hiroko H Dodge; Beth Snitz; Mary Ganguli
Journal:  J Am Geriatr Soc       Date:  2008-11-03       Impact factor: 5.562

10.  Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome.

Authors:  Nicole Schupf; Bindu Patel; Deborah Pang; Warren B Zigman; Wayne Silverman; Pankaj D Mehta; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.